title: [Steroid-induced hyperglycemia, a common clinical problem in medicine without evidence-based guidelines].
abstract: Even though corticoid-induced diabetes is an important clinical finding, there is still a clear lack of investigations in this field. In the last decades research has been conducted on the molecular regulation of the major anti-inflammatory actions of glucocorticoids and their side effects. Currently, insulin still remains the best current management option available to prevent middle and long-term consequences of repeated hyperglycemias. Some therapeutic suggestions are discussed, especially with the type of corticosteroid given, remaining as pragmatic as possible to improve adherence. Our objective is to review the current literature on glucocorticoid-induced hyperglycemia and current treatment strategies.
authors.affiliation: Service de médecine interne, Département de médecine, CHCVs, 1951 Sion. pauline.genolet@hopitalvs.ch
authors.forename: Pauline
authors.initials: P
authors.lastname: Genolet
authors.forename: Christophe
authors.initials: C
authors.lastname: Petite
authors.forename: Pierre-Auguste
authors.initials: PA
authors.lastname: Petignat
mesh_terms: D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced* / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D007328:Insulin